{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T17:01:52Z","timestamp":1773939712041,"version":"3.50.1"},"reference-count":24,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100013041","name":"Vice-Chancellor for Research, Shiraz University of Medical Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100013041","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004320","name":"Shiraz University of Medical Sciences","doi-asserted-by":"publisher","award":["18191"],"award-info":[{"award-number":["18191"]}],"id":[{"id":"10.13039\/501100004320","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Affective Disorders"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.jad.2025.120986","type":"journal-article","created":{"date-parts":[[2025,12,21]],"date-time":"2025-12-21T15:33:37Z","timestamp":1766331217000},"page":"120986","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["The role of fingolimod in managing anxiety and depression in patients with multiple sclerosis"],"prefix":"10.1016","volume":"397","author":[{"given":"Maryam","family":"Poursadeghfard","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Donya","family":"Shadfar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mahsa","family":"Kalaee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Etrat","family":"Hooshmandi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mahnaz","family":"Bayat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"10","key":"10.1016\/j.jad.2025.120986_bb0005","doi-asserted-by":"crossref","first-page":"e729","DOI":"10.1016\/S2468-2667(21)00047-5","article-title":"Prevalence and variability of current depressive disorder in 27 European countries: a population-based study","volume":"6","author":"Arias-de la Torre","year":"2021","journal-title":"Lancet Public Health"},{"issue":"12","key":"10.1016\/j.jad.2025.120986_bb0010","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1016\/j.biopsych.2023.11.010","article-title":"Mapping the relationship of white matter lesions to depression in multiple sclerosis","volume":"95","author":"Baller","year":"2024","journal-title":"Biol. Psychiatry"},{"issue":"4","key":"10.1016\/j.jad.2025.120986_bb0015","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2025.4751","article-title":"Uncinate fasciculus lesion burden and anxiety in multiple sclerosis","volume":"8","author":"Baller","year":"2025","journal-title":"JAMA Netw. Open"},{"issue":"3","key":"10.1016\/j.jad.2025.120986_bb0020","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1007\/s40268-020-00316-1","article-title":"Fingolimod as a treatment in neurologic disorders beyond multiple sclerosis","volume":"20","author":"Bascunana","year":"2020","journal-title":"Drugs R D."},{"issue":"5","key":"10.1016\/j.jad.2025.120986_bb0025","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1177\/1756285616651197","article-title":"Combination treatment of fingolimod with antidepressants in relapsing-remitting multiple sclerosis patients with depression: a multicentre, open-label study - REGAIN","volume":"9","author":"Bayas","year":"2016","journal-title":"Ther. Adv. Neurol. Disord."},{"key":"10.1016\/j.jad.2025.120986_bb0030","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.jns.2016.11.067","article-title":"Prevalence of depression and anxiety in Multiple Sclerosis: a systematic review and meta-analysis","volume":"372","author":"Boeschoten","year":"2017","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.jad.2025.120986_bb0035","doi-asserted-by":"crossref","DOI":"10.3389\/fncel.2020.00169","article-title":"Inflammation-associated synaptic alterations as shared threads in depression and multiple sclerosis","volume":"14","author":"Bruno","year":"2020","journal-title":"Front. Cell. Neurosci."},{"issue":"3","key":"10.1016\/j.jad.2025.120986_bb0040","doi-asserted-by":"crossref","DOI":"10.1002\/prp2.135","article-title":"Antidepressant activity of fingolimod in mice","volume":"3","author":"di Nuzzo","year":"2015","journal-title":"Pharmacol. Res. Perspect."},{"issue":"13","key":"10.1016\/j.jad.2025.120986_bb0045","first-page":"6018","article-title":"The association between fingolimod and mental health outcomes in a cohort of multiple sclerosis patients with stress","volume":"27","author":"Gammoh","year":"2023","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"issue":"19","key":"10.1016\/j.jad.2025.120986_bb0050","doi-asserted-by":"crossref","first-page":"3231","DOI":"10.1016\/j.neuron.2024.05.025","article-title":"Neurodegeneration and demyelination in multiple sclerosis","volume":"112","author":"Garton","year":"2024","journal-title":"Neuron"},{"issue":"1","key":"10.1016\/j.jad.2025.120986_bb0055","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1186\/s12955-020-01429-6","article-title":"Factor structure and reliability of Persian version of hospital anxiety and depression scale in patients with breast cancer survivors","volume":"18","author":"Hajian-Tilaki","year":"2020","journal-title":"Health Qual. Life Outcomes"},{"issue":"3","key":"10.1016\/j.jad.2025.120986_bb0060","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1097\/WCO.0000000000000699","article-title":"Diagnosis of multiple sclerosis: revisions of the McDonald criteria 2017 - continuity and change","volume":"32","author":"Hartung","year":"2019","journal-title":"Curr. Opin. Neurol."},{"key":"10.1016\/j.jad.2025.120986_bb0065","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.jns.2016.03.024","article-title":"Impact of a switch to fingolimod on depressive symptoms in patients with relapsing multiple sclerosis: an analysis from the EPOC (Evaluate Patient OutComes) trial","volume":"365","author":"Hunter","year":"2016","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.jad.2025.120986_bb0070","doi-asserted-by":"crossref","DOI":"10.3389\/fpsyg.2021.794353","article-title":"Psychometric properties of the HADS measure of anxiety and depression among multiple sclerosis patients in Croatia","volume":"12","author":"Jerkovic","year":"2021","journal-title":"Front. Psychol."},{"key":"10.1016\/j.jad.2025.120986_bb0075","article-title":"Inflammatory proteins related to depression in multiple sclerosis: a systematic review and meta-analysis","volume":"43","author":"Kiropoulos","year":"2025","journal-title":"Brain Behav Immun Health."},{"issue":"11","key":"10.1016\/j.jad.2025.120986_bb0085","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1177\/1352458511411061","article-title":"Oral fingolimod (FTY720) in relapsing multiple sclerosis: impact on health-related quality of life in a phase II study","volume":"17","author":"Montalban","year":"2011","journal-title":"Mult. Scler."},{"key":"10.1016\/j.jad.2025.120986_bb0090","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/1477-7525-1-14","article-title":"The Hospital Anxiety and Depression Scale (HADS): translation and validation study of the Iranian version","volume":"1","author":"Montazeri","year":"2003","journal-title":"Health Qual. Life Outcomes"},{"issue":"1\u20132","key":"10.1016\/j.jad.2025.120986_bb0095","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1159\/000451077","article-title":"Anxiety and coping strategy changes in multiple sclerosis patients initiating fingolimod: the GRACE prospective study","volume":"77","author":"Moreau","year":"2017","journal-title":"Eur. Neurol."},{"key":"10.1016\/j.jad.2025.120986_bb0100","article-title":"Prevalence of depression and anxiety in the different clinical forms of multiple sclerosis and associations with disability: a systematic review and meta-analysis","volume":"24","author":"Peres","year":"2022","journal-title":"Brain Behav Immun Health."},{"issue":"13","key":"10.1016\/j.jad.2025.120986_bb0105","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1212\/WNL.0000000000004411","article-title":"Neuroinflammation drives anxiety and depression in relapsing-remitting multiple sclerosis","volume":"89","author":"Rossi","year":"2017","journal-title":"Neurology"},{"issue":"3","key":"10.1016\/j.jad.2025.120986_bb0110","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1007\/s40120-025-00728-8","article-title":"Understanding depression in people living with multiple sclerosis: a narrative review of recent literature","volume":"14","author":"Sullivan","year":"2025","journal-title":"Neurol Ther."},{"key":"10.1016\/j.jad.2025.120986_bb0115","article-title":"The prevalence and risk factors of anxiety in multiple sclerosis: a systematic review and meta-analysis","volume":"17","author":"Zhang","year":"2023","journal-title":"Front. Neurosci."},{"issue":"6","key":"10.1016\/j.jad.2025.120986_bb0120","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1111\/j.1600-0447.1983.tb09716.x","article-title":"The Hospital Anxiety and Depression Scale","volume":"67","author":"Zigmond","year":"1983","journal-title":"Acta Psychiatr. Scand."},{"key":"10.1016\/j.jad.2025.120986_bb0125","doi-asserted-by":"crossref","DOI":"10.3389\/fpsyt.2021.665019","article-title":"Prevalence of mental disorders in the WHO Eastern Mediterranean Region: a systematic review and meta-analysis","volume":"12","author":"Zuberi","year":"2021","journal-title":"Front. Psychiatry"}],"container-title":["Journal of Affective Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165032725024280?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165032725024280?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T15:55:00Z","timestamp":1773935700000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165032725024280"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":24,"alternative-id":["S0165032725024280"],"URL":"https:\/\/doi.org\/10.1016\/j.jad.2025.120986","relation":{},"ISSN":["0165-0327"],"issn-type":[{"value":"0165-0327","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The role of fingolimod in managing anxiety and depression in patients with multiple sclerosis","name":"articletitle","label":"Article Title"},{"value":"Journal of Affective Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jad.2025.120986","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"120986"}}